Journal of Biomed Research

Continuous, non-invasive optical brain pulse monitoring (OBPM; Cyban Pty. Ltd., Melbourne, Australia) represents a significant advancement in the field of neurological monitoring. OBP monitoring uses red and infrared light sources to capture cardiac and respiratory waves from brain pulse waveforms, which reflect changes in both brain oxygen levels and brain movement.

For thousands of years, simulations have been used by doctors for training before performing high-risk procedures on patients. Due to changes in healthcare and academic environments, as well as the introduction of new technologies, we have seen an increase in the use of simulation for education and competency assessment.

Although human civilization has developed through genomic evolution, including its fingernail-functional cooperation, the daily lives of humans have resulted in a significant amount of carbon dioxide (CO₂) being released into the atmosphere since the Industrial Revolution, which started almost 200 years ago. Recently, climate change has been documented to have spread globally.

Anesthetic recovery can be a critical period since neurocognitive problems such as agitation and delirium are often seen during the early recovery phase. We recently demonstrated that an α2-adrenergic agonist dexmedetomidine-induced unconsciousness and accompanying brain dynamics changes were completely and instantly reversed by the α2-adrenergic antagonist in the nonhuman primate model.

We recently found that global deletion of TRPC1 produces phenotypes similar to FHH. These TRPC1 null mice have mildly elevated serum Ca in both fasted and unfasted conditions from 3.5 through 21.5 months of age, and inappropriately elevated parathyroid hormone (PTH) levels. They also have hypocalciuria, similar to FHH patients.

The optimal range of cell dose, route of administration, and timing for the treatement of neonatal encephalopathy are not known. However, it is not practical to systematically interrogate all combinations of these variables in animal models to define the optimal cell therapy protocol. Despite this limitation, a number of trends are present in the literature that should be considered when designing future clinical and preclinical trials.

The clustered regularly interspaced short palindromic repeats (CRISPR) Cas (CRISPR6 associated protein) system is an advanced adaptive immune system found in prokaryotes. First discovered in1987, CRISPR Cas has revolutionized genetic research in the past two decades. CRISPR-Cas9 the most widespread system enables precise gene editing by creating double strand breaks.

Anesthetic recovery can be a critical period since neurocognitive problems such as agitation and delirium are often seen during the early recovery phase. We recently demonstrated that an α2-adrenergic agonist dexmedetomidine-induced unconsciousness and accompanying brain dynamics changes were completely and instantly reversed by the α2-adrenergic antagonist in the nonhuman primate model.

We recently found that global deletion of TRPC1 produces phenotypes similar to FHH. These TRPC1 null mice have mildly elevated serum Ca in both fasted and unfasted conditions from 3.5 through 21.5 months of age, and inappropriately elevated parathyroid hormone (PTH) levels. They also have hypocalciuria, similar to FHH patients.

A recent article published by Abbas et al. in the Journal of Biomedicine and Pharmacotherapy systematically revealed about the vaccines developed against the recent pandemic agents SARS-CoV-2 and its variants [1]. The authors insightfully provided an overview on the distinct features of the SARS-CoV-2 new variants, the associated mortality rate, hospitalization, re-infection and finally the efficacy of different vaccines.

Expectancy-Value theory was originally proposed by John William Atkinson in the 1950s and 60s as an attempt to understand different behaviors of students including persistence, decision making when given multiple opportunities to choose from, and the effort of striving for success.

This paper interprets subjective psychological time in a model of consciousness called the HLbC model proposed by the authors. Time has an objective physical time and a subjective psychological time. Subjective psychological time is thought to vary in its flow depending on the individual and the situation. For this explanation, this paper introduces surreal numbers into the perception of subjective psychological time.

For thousands of years, simulations have been used by doctors for training before performing high-risk procedures on patients. Due to changes in healthcare and academic environments, as well as the introduction of new technologies, we have seen an increase in the use of simulation for education and competency assessment.

Although human civilization has developed through genomic evolution, including its fingernail-functional cooperation, the daily lives of humans have resulted in a significant amount of carbon dioxide (CO₂) being released into the atmosphere since the Industrial Revolution, which started almost 200 years ago. Recently, climate change has been documented to have spread globally.

In this commentary, we provide further discussion and interpretation of a recent article entitled “Blending into the Crowd: Electrophysiological Evidence of Gestalt Perception of a Human Dyad”, published one year ago by the first author of the present commentary. Firstly, drawing a parallel between the experiment described in the above article and another closely comparable experimental study, we propose that the neural integration process evidenced when seeing two human shapes close in space is a marker of the categorization of a stimulus as a group of humans (two here) represented as an entity per se.

The optimal range of cell dose, route of administration, and timing for the treatement of neonatal encephalopathy are not known. However, it is not practical to systematically interrogate all combinations of these variables in animal models to define the optimal cell therapy protocol. Despite this limitation, a number of trends are present in the literature that should be considered when designing future clinical and preclinical trials.

A recent article published by Abbas et al. in the Journal of Biomedicine and Pharmacotherapy systematically revealed about the vaccines developed against the recent pandemic agents SARS-CoV-2 and its variants [1]. The authors insightfully provided an overview on the distinct features of the SARS-CoV-2 new variants, the associated mortality rate, hospitalization, re-infection and finally the efficacy of different vaccines.